Digital Genome Market to Witness Widespread Expansion During 2020-2027

 The global digital genome market is expected to witness tremendous growth during the forecast period. Digital genome can be used in the diagnosis of rare diseases, genetic diseases, cancer, neurological disorders and others. The rising prevalence of chronic diseases such as breast cancer is driving the market growth. Other essential factors influencing the growth of the market are increasing geriatric population, need for efficient diagnosis and treatment, increasing number of drug discoveries, growing biotech sector, increasing research in the field of genomics and rise in funding related to digitalization. Variants of Presenilin gene lead to Alzheimer’s disease. According to Alzheimer's Association in 2018, 5.7 million people are from Alzheimer’s disease in the Americas. With the help of digital genome identifying genomic variants is easy.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1125 

However, factors such as high costs of digital genome techniques, lack of knowledge about the digital genome, security issues and inaccurate results are some of the factors expected to hinder the market growth during the forecast period.

Global Digital Genome Market, by Key Players

• Umbel
• BiogeniQ
• GenomeMe
• NanoString
• Illumina, Inc

Segmentation

The global digital genome market is segmented on the basis of product, application, and end-user.  The global digital genome market, by product, is segmented into sequencing services, sequencing instruments, sequencing consumables, bioinformatics and sample preparation kits and reagents. The application segment is segmented into diagnostics, agriculture & animal research, personalized medicine, drug discovery and treatment analysis.  On the basis of end-user, the market is categorized into research centers and government institutes, academic institutions, pharmaceutical & biotechnology industries, hospitals, and diagnostic centers. On the basis of region, the global digital genome market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Regional Market Summary

The digital genome market is dominated by America owing increasing prevalence of chronic diseases like cancer and diabetes. The Breastcancer.org estimated 266,120 new cases of invasive breast cancer and 63,960 new cases of non-invasive breast cancer in America in 2018. Thus, this provides favorable backgrounds for the market to grow.

It is estimated that Europe stood second in the global digital genome market. The rising demand for personalized medicine and targeted therapy is driving the growth of the market. The European Alliance for Personalized Medicine (EAPM) founded in March 2012, is involved in enhancing patient care for chronic diseases through personalized medicine. According to the European Commission in April 2018, 13 European countries have signed a declaration to share the genomic data to allow personalized treatments against cancer, rare diseases, and neurological diseases.

The digital genome market in Asia-Pacific is expected to witness growth owing to rising diabetes in this region. According to the American Diabetes Association in 2016, the Western Pacific has more than 138.2 million diabetic patients. Also, the rising healthcare spending and growing biotech sector drive the market growth in this region.

The Middle East and Africa holds the least share in the global digital genome market due to low funding in medical and health research. However, the rising prevalence of chronic diseases and increasing healthcare spending favors market growth in this region. According to the Ministry of Finance - KSA (Kingdom of Saudi Arabia) in 2018, 147 billion riyals (USD 39.2 billion) have been allocated for the Health and Social Development Sector. This enhances the market growth of digital genome in this region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/digital-genome-market-1125 

Medical Holography Market Growth, Trends and Value Chain 2020-2027

 A holography is a method of producing a three-dimensional image of an object using an interference pattern. The existing 3D technologies such as 3D-CT, 3D rotational angiography, 3D-ultrasound revolutionized medicine because they allowed doctors to see an individual patient's anatomy without cutting into the body. The exceptional penetration rate of holography products is attributable to the natural benefits of this technology over conservative alternatives, which influence companies to work further toward developing these products for subsequent commercialization.

The global medical holography market is majorly driven by factors such as rapid adoption of holography technology by medical fraternity for applications such as medical education, dentistry, orthopedics, increasing applications of holography in diagnostic imaging to visualize complex 3D structures in human body and biomedical research recent technological advancements in holography products are expected to significantly contribute to the growth of the market throughout the forecast period. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1519 

Technological advances in hologram recording techniques in the recent years and the availability of tools for interpretation of holographic interferograms should boost its usage in the field of urology, pathology, ophthalmology, and orthopedics. Moreover, endoscopic holography should emerge as a powerful tool for non-contact high resolution and non-invasive measurements inside the human organs.

The market for Medical holography will grow very rapidly at a rate of 32% CAGR during the forecasted period 2017-2023. The market is expected to reach USD 3.5 billion during the forecasted period.

Industry updates:

Nov, 2016 Holoxica Limited introduced a holographic 3D digital human anatomy atlas prototype for neuroscience. This product impacted medical science giving neurosurgeons and clinicians insights into identifying, diagnosing and treating a wide range of neurological conditions.

Dec, 2015 Japan scientists developed touchable holograms, which are to be adopted in wide range of applications in the future, to enable improved demonstration of biological processes and procedures.

Nov, 2015 Zebra Imaging acquired Rattan, a software-consulting firm. This acquisition was carried out to accelerate the integration of advanced 3D light-field technology in their array of holographic display products.

Dec, 2014 Bristol University developed a touchable holographic display through the generation of air disturbances using ultrasound to create 3D haptic shapes.

Oct, 2014 Zebra Imaging entered into a partnership with Zygote Media Group to develop advanced 3D biomedical models to visualize human anatomy.

Oct, 2013 RealView Imaging Ltd. and Royal Philips completed an assessment of live 3D holographic imaging, which facilitates 3D interaction and facilitates minimally-invasive structural heart disease procedures.

Sept, 2012 Zebra Imaging, Inc.’s digital print technologies have proven useful in medical, military, retail, and other commercial disciplines. This acquisition will add new products to HoloTech AG’s product portfolio, which will also help the company to expand its presence in holographic digital print operations.

Global Medical holography Market – Regional:

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

America accounts the larger market for the hologram machines. As the early adoption of new technologies and more R&D is being carried out in this region. North America is the largest market for the hologram machines which is led by the United States. The adoption of new technology is more in this region as the research and development is also more and developing day by day.

Europe is the second largest market as it also has the advanced technologies and its own R&D. The region is also having its own set of regulations for the medical regulations. The expenditures are also more by the government bodies for the healthcare and adoption for the new and sophisticated technologies.

The Asia-Pacific region is witnessing fast growth in this region because of the rising factors such as healthcare spending, improving healthcare infrastructure in developing economies such as China, India, and South Korea, and growing awareness regarding the usage of holography products in medical applications.

The Middle East and Africa region is growing slowly due to factors like large number of unskilled labours, illiteracy is more, and economic development is slow.

Real View Imaging (Israel), Echo Pixel (CA), Integraf (USA), Royal Philips (Netherland), Zebra imaging, Eon Reality (US), Nano live SA (Switzerland), Holoxcia (Engalnd), Lyncee Tec (Switzerland), Mach 7 Technologies, General Electric Company, DPL Industri A/S Denmark, Olomagic, Arnold Herzig GmbH and others are some of the prominent players at the forefront of competition in the global medical holography treatment market and are profiled in MRFR Analysis.  

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-holography-market-1519 

Cataract Surgery device Market to Witness Widespread Expansion During 2020-2027

 The globally market for cataract surgery device is growing steadily. Factors that influence the cataract surgery device market are increasing prevalence of cataract surgery, increasing advance technology in cataract surgery device market, increase in the aging population, prevalence of eye disease and many others. Globally the market for cataract surgery device is expected to grow at the rate of about 5.5% from 2016 to 2022.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2115  

Market Drivers and Restraints:

The occurrence of cataract is very common in the elderly population. Other causative agents of cataract are trauma and long-time exposure to radiations. The increasing prevalence of cataract among geriatric population all over the world is inducing high demand for efficient surgical devices to perform cataract surgery. The rise in preference for less invasive procedures has created huge opportunities for the manufacturers to introduce high-tech ophthalmic surgical devices, leading to the expansion of the global cataract surgery device market.

The government sector in various countries are focusing on increasing awareness regarding cataract and are undertaking the initiatives to provide low-cost cataract surgeries in underdeveloped regions, which in turn is fueling the growth of the global cataract surgery device market. The rise in adoption of advanced technology in the healthcare sector for improving the diagnostics, surgical and treatment procedures is impacting positively on the expansion of the global cataract surgery device market.

However, the population in underdeveloped regions is still unaware of the benefits of cataract surgery, which is negatively impacting on the growth of the global cataract surgery device market. The low penetration of advanced technology and poor primary healthcare infrastructure in underdeveloped regions and in some areas of developing regions are likely to create hindrance in the growth of the global cataract surgery device market during the forecast period.

Market Segmentation:

The global cataract surgery devices market has been segmented on the basis of device type and end-users. Based on device type, the global cataract surgery device market is segmented into Intraocular lens (IOL), Ophthalmic Viscoelastic Device (OVD), Phacoemulsification Equipment and Femtosecond Laser Equipment. Among these, the intraocular lens (IOL) segment is anticipated to project significant growth in the global cataract surgery device market during the forecast period. Based on end-users, the global cataract surgery device market is segmented into hospitals, clinics, ophthalmology centers and others.

Regional Analysis:

The global cataract surgery device market is segmented into five major regions such as North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Owing to the rapid incorporation of advanced technology in the healthcare sector and increased healthcare expenditure, the North America region is projecting to be the largest market in the global cataract surgery device market.

The Europe region is the second largest market in the global cataract surgery device market due to the increasing incidences of individual suffering from cataract. The high geriatric population and increasing awareness among the population regarding the benefits of cataract surgery are leading to the fastest growth of the global cataract surgery device market. The lack of awareness and poor primary healthcare infrastructure in the underdeveloped areas are negatively impacting on the growth of the cataract surgery device market in the Middle East and Africa region.

Competitive Analysis:

The rapid technological advancement is facilitating the manufacturers to introduce upgraded surgical devices in the global cataract surgery devices market, which in turn is strengthening the competition among the players of the global cataract surgery device market.

On 17Th July 2018, Amring Pharmaceutical Inc., a generic pharmaceutical company, has announced the launch of its latest product, Biolon OVD (Ophthalmic Viscosurgical Device), which will be used while performing cataract surgery.

The key players in the global cataract surgery device market that are profiled in the report published by MRFR are Alcon, Inc. (the U.S), Abbott Laboratories (the U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), Opcon Corporation (Japan), Allergan, Inc. (the U.S.), Bausch & Lomb, Inc. (the U.S.), NIDEK Co., Ltd. (Japan), STAAR Surgical Company (the U.S.) and others.      

For More Report Details @ https://www.marketresearchfuture.com/reports/cataract-surgery-device-market-2115 

 
 
About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

CPAP Devices Market – Insights on Upcoming Trends 2027

 Continuous positive airway pressure (CPAP) devices are used in the treatment of choice for obstructive sleep apnea syndrome. CPAP works by blowing air into the nose and throat. The blow causes a positive pressure to hold the upper airway open during sleep and thus helps in the treatment of snoring. This device typically used when the patient has a breathing problem. Additionally, it increases the air pressure in the throat to avoid airway from collapsing when breathing. It can be used every night at home while sleeping. The global CPAP market is majorly driven by increasing number of patients with sleep apnea, obesity, and other respiratory diseases. According to the World Health Organization (WHO), in 2016, more than 1.9 billion adults, above 18 years were overweight. Out of these over 650 million were obese. The report also suggests that over 340 million children and adolescents aged 5-19 were overweight or obese in 2016. Thus, rising number of patient with obesity generating the exponential demand for CPAP devices market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/939 

According to the WHO, in 2016, around 39% of 41 million children under the age of 5 were overweight or obese. Advances in technology such as improved mask design, oral appliances, use of oxygen devices, rising healthcare expenditure, and increasing demand for the devices have fuelled the market growth. However, CPAP is not always effective since some patients find it uncomfortable and sometimes it shows adverse effects. The high cost of the devices and their adverse effect may slow the market growth.

Global continuous positive airway pressure (CPAP) devices market is expected to grow at a CAGR of 7.1% during the forecast period 2017-2027. 

Segmentations

Global continuous positive airway pressure (CPAP) devices market is segmented on the basis of product type, features, automation, and end user

On the basis of the product type, it is segmented into CPAP motors, CPAP hoses, CPAP mask, and others.

On the basis of the features, it is segmented into the humidifier, portability, heated tubing, and others.

On the basis of the automation, it is segmented into manual and automatic.

On the basis of the end user, it is segmented into hospitals, private clinics, home care, and others.

Regional Analysis

The Americas hold the largest share of the global market owing to increasing incidence of obesity, unhealthy diet, and physical inactivity. According to the updated report by the Centers for Disease Control and Prevention (CDC) in 2017, a total number of adults diagnosed with chronic bronchitis in the past year was 9.3 million. The report further adds that around 3.8% of the total adult population in the U.S. diagnosed with chronic bronchitis, in 2016. Presence of well-developed technology, high health care spending, increased R&D activities, and the concentration of major companies have fuelled the growth of the market in this region.

Europe holds the second position followed by the Asia Pacific in the global CPAP devices market owing to the rising patient population diagnosed with respiratory diseases. Furthermore, the government support for research & development and availability of funds for research are likely to fuel the CPAP devices market growth over the forecast period.

Asia Pacific is the fastest growing CPAP devices market owing to unhealthy diet and associated lifestyle changes. Moreover, the increased presence of rapidly developing healthcare technology, high healthcare expenditure, R&D activities, and the concentration of major companies are fuelling the growth of the market in this region. Increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe.

On the other hand, the Middle East and Africa account for the lowest share of the global market owing to lack of technical knowledge and poor medical facilities. 

Key Players

Some of key the players in the market are Medtronic (U.S.), Koninklijke Philips N.V. (the Netherlands), 3B Medical, Inc. (U.S.), Armstrong Medical Inc. (U.S.), ResMed (U.S.), Smiths Medical (U.S.), Apex Medical Corp. (Taiwan), Fisher & Phillips LLP (U.S.), Cardinal Health (U.S.) Beijing Dehaier Medical Technology Co., Ltd. (China), DeVilbiss Healthcare LLC (US), and Invacare Corporation (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/continuous-positive-airway-pressure-devices-market-939 

 

About US: 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

Human Insulin Market to Witness Widespread Expansion During 2020-2027

 Global Human Insulin Market is expected to grow at CAGR of 12.10% to reach USD 90,812.40 Million till 2025. Human insulin in the report refers to synthetic insulin manufactured in laboratories by increasing insulin protein with the help of e. coli bacteria. Human insulin can be administered orally or through insulin infusion devices. Some conventional insulin infusion devices are syringes, injection pens, and insulin pumps. These devices are used to deliver insulin on time and regularly.

Increasing prevalence of diabetes, rising obesity endemic, rise in geriatric population, and increasing awareness among people about diabetic care and technological advancement in delivery devices of insulin are some of the factors influencing the growth of the human insulin market. However, strict regulatory requirements for approval of insulin and high cost of insulin analog inhibit the growth of the human insulin market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/951 

Market Dynamics

The increasing affordability of human insulin is one of the key factors driving the human insulin market. In May 2019, Eli Lilly and Company launched Insulin Lispro Injection for people who use Lilly's rapid-acting insulin and need a lower-cost option. Insulin Lispro Injection has a 50% lower price than its identical medicine, Humalog U-100 (insulin lispro injection).

Increasing diabetic population is also strongly impacting the growth of the market. Diabetes is a chronic and non-communicable disease, and its global prevalence is rising enormously. Nowadays, it is one of the leading causes of death and has an increased risk of developing several serious health problems. It is the primary cause of cardiovascular diseases, kidney diseases, eye disorders, and strokes.

As per 2017, National Diabetes Statistic Report suggested by the Centers for Disease Control and Prevention, more than 100 million people in the US have diabetes or prediabetes.

Segmentation

Based on type, the global human insulin market has been segmented into traditional human insulin and modern human insulin. Traditional human insulin segment includes premixed traditional, intermediate-acting, and short-acting. Modern human insulin segment includes premixed modern, long-acting, and rapid-acting. Modern human insulin was the leading segment in 2018. Modern human insulin, also known as analog insulin, is prescribed by physicians for the treatment of diabetes. It is the customized form of traditional human insulin and provides effective results in comparison to traditional human insulin.

The global human insulin market, by brand, has been segmented into Lantus, Novorapid, Humalog, Novomix, Levemir, Apidar, Humulin, and Insuman. Lantus is a long-acting human insulin analog, and it is available in more than 120 countries. Among all the brands, Lantus commands the largest share in the human insulin market. Apidra is a rapid acting human insulin analog. Also, Apidra and Levemir are the fastest growing brand in the human insulin market. Moreover, there are various drugs in the pipeline, which would have a positive impact on the growth of the market in the coming years.

Regional Analysis

The global human insulin market has been categorized as the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas dominate the global human insulin market, owing to the growing old age population, increasing healthcare awareness, rising prevalence of diabetes, improvement in reimbursement policies, and increasing clinical trials driving the growth of human insulin.

The European Human Insulin market has been segmented into Western Europe and Eastern Europe. In 2018, Europe stood second in the global Human Insulin market. Increasing focus on the treatment of diabetes and rising clinical trials by market players will support the growth of Europe Human Insulin market. For instance, a France-based firm, Adocia received positive topline pharmacodynamic and safety results from the first Phase 1 study of ADO09. ADO09 is intended to improve postprandial glucose control and long-term outcomes for people requiring prandial insulin treatment.

Asia-Pacific is expected to register the highest CAGR during the forecast period. Companies are introducing new advanced products in this region, which is boosting Asia-Pacific human insulin market. In March 2018, Biocon Ltd and Mylan NV received approval for biosimilar insulin glargine Semglee 100 IU/mL 3 mL prefilled pen from the Therapeutic Goods Administration (TGA) Australia.

On the other hand, the Middle East & Africa holds the least share in the global human insulin market due to the low economic development, especially within the African region.

Key Players

The prominent players in the global human insulin market are ADOCIA, MERCK & CO., INC., Julphar, Pfizer Inc., Bristol-Myers Squibb Company, GLAXOSMITHKLINE PLC, SANOFI, Oramed, Novo Nordisk India Pvt. Ltd, Eli Lilly and Company, BIOCON, and Tonghua Dongbao Pharmaceutical Co., Ltd.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/human-insulin-market-951 

 

About US: 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

Maternal health Market to Witness Widespread Expansion During 2020-2027

 Market Scenario

Every year the death of women is high because of the pregnancy complications. The number is much reduced in the todays date. The reason behind this is government initiatives, the government is trying to help pregnant women for their better health of mother and baby. The best example of the initiatives can be seen by UNICEF (India). The program they have started is Janani Shishu Suraksha Karyakaram (JSSK) scheme which provides free maternity service across India. The services are provided to increase number of emergency referral systems and maternal death audits, and improvements by government and management for health services. Every year near about 800 women die in the world. India contributes 20% in this number of 800. The number of deaths are being controlled by the WHO, CDC and UNICEF programs. The education is given to women and the health services are provided at large to women. Adolescent women are at risk of the complications during pregnancy, these women are provided with health services. The post pregnancy services are also provided to them.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/732 

The maternal health market will grow at a rate of 7% CAGR during the forecasted period 2017-2023. The deaths was found reduced in 2012 it was near approximately 175. This will be further reduced in coming years with the help of scheme like JSSK by UNICEF in India.

Study objectives:

• To provide detail analysis of the market structure along with estimated future growth forecast for the next 7years about various segments and sub-segments of the global maternal health market.
• To provide insights about factors affecting the market growth.
• To analyze the global maternal health market based on various factors - price analysis, supply chain analysis, Porters Five Force Analysis etc.
• To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries - Americas, Europe, Asia-Pacific along with Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future growth prospect.
• To provide country level analysis of the market’s segments which includes by type of pregnancy, by risk in pregnancy, by complications, by delivery type.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
• To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments currently taking place in the global  maternal health market.

Segments:       

The market of the maternal health is segmented into type of the pregnancy, risk in pregnancy and complications. Types of pregnancy includes Intrauterine, Ectopic, Tubal and Others. On the basis of risk occurred in pregnancy which have high risk and molar risk. On the basis of the complications like miscarriage, premature labor and birth, preeclampsia, gestational diabetes, placenta previa and others. The miscarriage further have sub segments like threatened, inevitable, complete, and incomplete.

Regional analysis:

Globally the deaths of women are increasing due to the complications during pregnancy. The market for the maternal health is divided into four main geographic regions. The main regions are Americas, Europe, Asia-Pacific and Middle East and Africa. Further the regions are divided into developed and developing countries falling under this regions. The deaths of women have increased in Americas despite of advanced medicine and technology over past 25years. The reason behind this is of heart conditions, blood pressure, bleeding and many more complications.
Intended Audience

• Government hospitals
• Private hospitals
• NGOs
• Medical Organizations and Institutes
• Pharmaceutical Companies

Key players of Global Maternal Health Market:

Some of the global and local players are engaged in the maternal health those are, Agile Therapeutics (USA), Fuji Latex Co (Japan), Okamoto industries, Reckitt Benckiser Group Plc.(UK), Sanofi (India), Johnson and Johnson(USA).
The report for Global Maternal Health Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/maternal-health-market-732 

 

About US: 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

Soaring Demand Drives Global Microfluidics Device Market Growth During the Forecast Period, 2020-2027

 Microfluidic devises Market overview

According to the latest report, the global Microfluidic Devices market size is predicted to reach USD 14,296.04 Million by the end of the year 2025 with a significant growth rate of CAGR of 19.70%.  A Microfluidic device utilizes the chemical and physical properties of gases and liquids at a micro-scale. This device provides various benefits over evenly sized systems. Microfluidics investigates and uses fewer samples volume, chemicals, and also decreases global fees of applications.  

The microfluidic device is an advanced technology that helps integrate several medical tests on a single chip. It is an important technology for miniaturization, integration, industrialization, and parallelization of several tests in different fields of biological research, in developments of drugs, and diagnosis. The rise in demand for the microfluidic technologies for miniaturization of the chip and testing products are the major driving factors for the growth of the Microfluidic Devices market. The increasing demand for genomics and proteomics are some other major driving factors. Moreover, the rigid policies of the government may hamper the growth of the global Microfluidic Devices market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/684 

This report contains all the information on the global Microfluidic Devices market research and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the global Microfluidic Devices market and forecast to 2025 is also included in the report.

Covid 19 Analysis

The outbreak of the global pandemic covid 19 has affected the global Microfluidic Devices market, by creating a burden on the laboratories due to the large numbers of cases that were supposed to be tested in the labs. Hence, there is some positive impact as well; Microfluidic is basically handling of a small number of fields in chambers and microscale channels. It helps the researchers to manage fewer amounts of samples and generates faster results as compared to the conventional methods, just because of the high potentials in advanced microfluidic technology. This technology is considered the promising technology in this global pandemic situation of covid 19.

Market Dynamic

•         Drivers

The advancement in the technology of diagnosis devices is the major factor propelling the growth of the global Microfluidic Devices market. Along with that, the rising incidence of chronic diseases and accordingly increased demand for Microfluidic technology has further boosted the demand for the global Microfluidic Devices market.

•         Opportunities

The current scenario of the market is witnessing major advancement in technology, as the developments in Microfluidic are leading towards the cost-effective mass production process of diagnostic devices. it is also creating various opportunities for the major key manufacturers in the market as well by pairing smartphones to Microfluidic which enables the deployment of point-of-care testing. The application of Microfluidic devices is likely to boost the demand for the Microfluidic devices market in the future.

•         Restraints

The lack of skilled technicians in the Microfluidic along with the issues related to the regulatory environment is the major restraint of the global Microfluidic market. The high cost of Microfluidics types of equipment is another major restraint especially in the developing countries as it is unaffordable due to the emerging low income of such countries.

•         Challenges

The major challenges faced by the key manufacturers of Microfluidic devices are to provide results immediately outside the conventional laboratory environment which involves point-of-care device market (POCT) testing. It is strongly impacting the growth of the global Microfluidic Devices market.

Cumulative Growth Analysis

The increasing advancement in technology is the major key driving factor for the Microfluidic device market. For instance, in the month of January 2019, L’Oreal has launched a prototype of a wearable sensor from the L’Oreal Technology Incubator at the show of Consumers Electronic in 2019 and also introduced a companion app. The first wearable microfluidic sensor was introduced by My Skin Track pH by La Roche-Posay and companion app which helps to easily measure the pH balance in skin and accordingly creates some customized product regimens for better care for the skin.

Value Chain Analysis

According to the latest report the global Microfluidic devices market has been segmented onto the basis of industry, materials, application, and regions. On the basis of industry, the global Microfluidic devices market has been segmented into pharmaceutical, medical devices, in-veto diagnostics, and others. The pharmaceutical segment is further segmented into chips for lab analytics, accurate dispensing devices, and micro-reactors for drug synthesis. The in-veto segments account for the maximum shares of 50.6% in the year 2018 due to the increasing demand for early diagnosis.

On the basis of materials, the global Microfluidic devices market has been segmented into glass, polymer, silicon, and others. The polymer segments account for the maximum share in the global Microfluidic devices market due to its fast fabrication process and cheaper costs as compared to the glass and silicon. On the basis of application the global Microfluidic devices market is segmented into pharmaceutical and life science research, clinical and veterinary diagnostics, point of care diagnostics, analytical devices, drug delivery, environmental and industrial, and others.

Segmentation Overview

The market is segmented on the basis of the industry, materials, application, and regions. The global Microfluidic devices market is expected to witness decent growth during the forecast period.

By Application

Based on the application, the market is segmented into pharmaceutical and life science research, clinical and veterinary diagnostics, point of care diagnostics, analytical devices, drug delivery, environmental and industrial, and others.

By End-users

Based on the propulsion types, the market is segmented into pharmaceutical, medical devices, in-veto diagnostics, and others.

Regional Analysis

According to the latest reports, the global Microfluidic devices market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East, and Africa. America accounts for the maximum share in the global Microfluidic devices market due to the rising geriatric population, increasing chronic diseases and lifestyle diseases, raising awareness in healthcare, and the developments in technologies for several applications and along with that the extensive insurance infrastructure facilities are driving the growth of the global Microfluidic Devices market.

Europe is expected to stand second in the global Microfluidic devices market due to advancements in technology and the support of the major levy players for the growth of the Microfluidic devices market. Asia Pacific is predicted to register the maximum CAGR during the forecast period due to the introduction of new advanced products in these regions. The Middle East & Africa holds the least Microfluidic devices market share due to the low development in the economy mainly in the African region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microfluidics-device-market-684 

 

About US: 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com